Medical Care Technologies Inc Stock Price, News & Analysis

Medical Care Technologies (OTC:MDCE) announced significant corporate developments following a remarkable 2,500% year-over-year revenue growth in Q2 2025. The company has initiated onboarding with a new transfer agency to facilitate its planned share reduction and corporate restructuring initiative.

MDCE's subsidiary Infinite Auctions reported strong Q2 results and has already secured sales exceeding $250,000 in Q3 2025. Meanwhile, its other subsidiary, Real Game Used, continues to expand in the sports collectibles authentication market. The company aims to create a more efficient capital structure while maintaining operational growth momentum.

Medical Care Technologies (OTC:MDCE) reported exceptional growth for its subsidiary Infinite Auctions, achieving $296,175 in Q2 2025 revenue, marking a dramatic 2,500% year-over-year increase from Q2 2024's $11,035.

The company's momentum continues into Q3 2025, with over $250,000 in secured sales already. This growth is driven by Infinite Auctions' consecutive auction series, culminating in the upcoming "Grail Collection" online auction on August 30, 2025. Additionally, MDCE's other subsidiary, Real Game Used, is expanding in the sports collectibles authentication market, though its revenue is not included in Q3 projections.

Real Game Used, a subsidiary of Medical Care Technologies Inc. (OTC Pink:MDCE), has introduced a dual authentication system for memorabilia verification. The company combines AI-assisted photo matching technology with traditional human expert analysis to authenticate game-worn sports items, screen-worn entertainment pieces, and celebrity memorabilia.

The company is positioning itself in a rapidly growing market, with the collectibles authentication sector projected to grow at 16% CAGR through 2033. The sports memorabilia market, valued at $33.6 billion in 2024, is expected to reach $271 billion by 2034, with a significant 22.1% CAGR.

Infinite Auctions, a subsidiary of Medical Care Technologies (OTC PINK:MDCE), has launched "The Grail Collection" online auction featuring five pairs of Michael Jordan game-worn sneakers. The auction, running through August 30, 2025, presents a rare opportunity for collectors to acquire authentic footwear worn by the six-time NBA Champion during actual NBA games.

CEO Marshall Perkins emphasizes the exceptional nature of offering multiple Jordan game-worn sneakers in a single auction event. The collection, available at www.infiniteauctions.com, is open to collectors worldwide and includes other rare sports memorabilia, with the Jordan sneakers serving as the centerpiece of the auction.

Medical Care Technologies (OTC:MDCE) has announced significant developments across multiple business fronts. The company's subsidiary Infinite Auctions is conducting its second high-profile auction of authenticated game-worn memorabilia, while Real Game Used (RGU) is making progress on clearing its authentication backlog.

MDCE has filed a patent application for its AI-assisted image analysis technology, which has potential applications in both medical diagnostics and sports memorabilia authentication. The company is also preparing for a share restructure following the completion of its transfer agent transition, aimed at enhancing long-term shareholder value.

Medical Care Technologies (OTC:MDCE) subsidiary Infinite Auctions has launched "The Grail Collection" Auction, featuring rare NBA memorabilia. The auction's highlight includes five game-worn Michael Jordan jerseys and an impressive collection of game-worn sneakers from legendary players like Allen Iverson, Magic Johnson, and Kobe Bryant.

The collection also features photo-matched game-worn jerseys from modern stars including Stephen Curry, Tracy McGrady, and Yao Ming. All items are authenticated by MDCE's subsidiary Real Game Used (RGU), utilizing their proprietary image-based authentication technology. The online auction runs through August 30, 2025 on infiniteauctions.com.

Medical Care Technologies (OTC:MDCE) has filed a U.S. Provisional Patent Application (No. 63/854,935) for its innovative AI-assisted imaging system. The technology targets two distinct markets: healthcare diagnostics and digital memorabilia authentication.

The AI system aims to enhance medical imaging analysis for improved clinical decision-making while also providing authentication solutions for items like game-worn sports memorabilia through AI-driven photo matching. The patent application was filed with support from intellectual property law firm PLAGER SCHACK LLP.

CEO Marshall Perkins emphasized the technology's potential to impact both healthcare and digital authentication markets through the combination of deep learning and computer vision.

Medical Care Technologies (OTC Pink:MDCE) subsidiary Infinite Auctions has sold a rare LeBron James Miami Heat NBA Finals jersey for $242,400. The jersey, from Game 4 of the 2014 NBA Finals, features verified provenance directly from Upper Deck and photo-match authentication.

The sale comes amid industry turmoil, with the sports memorabilia market facing challenges from fraudulent actors. In response, Infinite Auctions and sister company Real Game Used (RGU) are positioning themselves as industry leaders in transparency and authenticity.

The company also announced "The Grail Collection" auction, running August 2-30, featuring rare items including Michael Jordan sneakers and photo-matched jerseys from various NBA legends.

Medical Care Technologies (OTC Pink:MDCE) has unveiled its revolutionary AI Facial Age-Based Health Risk Estimator, a groundbreaking diagnostic tool that combines artificial intelligence with computer vision for preventive healthcare.

The platform analyzes facial biometric markers including micro-wrinkle density, skin elasticity, and tone variance to estimate biological age and assess risk for chronic conditions like cardiovascular disease and type 2 diabetes. The technology enables real-time, non-invasive screening through mobile apps, marking a shift from reactive to proactive healthcare.

This innovation positions MDCE to capitalize on the global preventive health market, which is projected to surpass $250 billion by 2030.